高级检索
当前位置: 首页 > 详情页

Ideal Cardiovascular Health Metrics and Major Cardiovascular Events in Patients With Prediabetes and Diabetes

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Shanghai Jiao Tong Univ, Shanghai Natl Clin Res Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis,Natl Hlth Com, Key Lab Endocrine & Metab Dis,Ruijin Hosp,Sch Med, Shanghai, Peoples R China [2]Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai, Peoples R China [3]Army Gen Hosp, Chinese Peoples Liberat, Beijing, Peoples R China [4]Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Hubei, Peoples R China [5]Zhejiang Prov Ctr Dis Control & Prevention, Hangzhou, Zhejiang, Peoples R China [6]Lanzhou Univ, Hosp 1, Lanzhou, Gansu, Peoples R China [7]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Wuhan, Hubei, Peoples R China [8]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou, Guangdong, Peoples R China [9]Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China [10]Luzhou Med Coll, Affiliated Hosp, Luzhou, Peoples R China [11]Fujian Med Univ, Fujian Prov Hosp, Fuzhou, Fujian, Peoples R China [12]Dalian Municipal Cent Hosp, Dalian, Peoples R China [13]Jilin Univ, Hosp 1, Changchun, Jilin, Peoples R China [14]Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China [15]Guangxi Med Univ, Affiliated Hosp 1, Nanning, Peoples R China [16]Shandong Univ, Qilu Hosp, Jinan, Shandong, Peoples R China [17]Nanchang Univ, Jiangxi Prov Peoples Hosp, Nanchang, Jiangxi, Peoples R China [18]Harbin Med Univ, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China [19]Cent Hosp Shanghai Jiading Dist, Shanghai, Peoples R China [20]Jiangsu Prov Hosp Integrat Chinese & Western Med, Nanjing, Jiangsu, Peoples R China [21]Anhui Med Univ, Affiliated Hosp 1, Hefei, Anhui, Peoples R China [22]Karamay Municipal Peoples Hosp, Xinjiang, Peoples R China [23]Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China [24]Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China [25]Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA [26]Johns Hopkins Univ, Sch Med, Baltimore, MD USA [27]Icahn Sch Med Mt Sinai, New York, NY 10029 USA [28]Guiyang Med Coll, Affiliated Hosp, Guiyang, Guizhou, Peoples R China [29]Shandong Univ, Shandong Prov Hosp, Jinan, Shandong, Peoples R China
出处:
ISSN:

摘要:
IMPORTANCE Whether optimal cardiovascular health metrics may counteract the risk of cardiovascular events among patients with prediabetes or diabetes is unclear. OBJECTIVE To investigate the associations of ideal cardiovascular health metrics (ICVHMs) with subsequent development of cardiovascular disease (CVD) among participants with prediabetes or diabetes as compared with participants with normal glucose regulation. DESIGN, SETTING, AND PARTICIPANTS The China Cardiometabolic Disease and Cancer Cohort Study was a nationwide, population-based, prospective cohort study of 20 communities from various geographic regions in China. The study included 111765 participants who were free from CVD or cancer at baseline. Data were analyzed between 2011 and 2016. EXPOSURES Prediabetes and diabetes were defined according to the American Diabetes Association 2010 criteria. Seven ICVHMs were adapted from the American Heart Association recommendations. MAIN OUTCOMES AND MEASURES The composite of incident fatal or nonfatal CVD, including cardiovascular death, myocardial infarction, stroke, and hospitalized or treated heart failure. RESULTS Of the 111765 participants, 24881 (22.3%) had normal glucose regulation, 61024 (54.6%) had prediabetes, and 25860 (23.1%) had diabetes. Mean (SD) age ranged from 52.9 (8.6) years to 59.4 (8.7) years. Compared with participants with normal glucose regulation, among participants with prediabetes, the multivariable-adjusted hazard ratio for CVD was 1.34 (95% CI, 1.16-1.55) for participants who had 1 ICVHM or less and 0.57 (95% CI, 0.43-0.75) for participants who had at least 5 ICVHMs; among participants with diabetes, the hazard ratios for CVD were 2.05 (95% CI, 1.76-2.38) and 0.80 (95% CI, 0.56-1.15) for participants who had 1 ICVHM or less and at least 5 ICVHMs, respectively. Such pattern of association between ICVHMs and CVD was more prominent for participants younger than 55 years (prediabetes and at least 5 ICVHMs: hazard ratio [HR], 0.32; 95% CI, 0.16-0.63; 1 ICVHM or less: HR, 1.58; 95% CI, 1.13-2.21; diabetes and at least 5 ICVHMs: HR, 0.99; 95% CI, 0.44-2.26; 1 ICVHM or less: HR, 2.46; 95% CI, 1.71-3.54; compared with normal glucose regulation) than for participants 65 years or older (prediabetes and at least 5 ICVHMs: HR, 0.80; 95% CI, 0.50-1.26; 1 ICVHM or less: HR, 1.01; 95% CI, 0.79-1.31; diabetes and at least 5 ICVHMs: HR, 0.79; 95% CI, 0.46-1.35; 1 ICVHM or less: HR, 1.73; 95% CI, 1.36-2.22, compared with normal glucose regulation; P values for interaction <=.02). Additionally, the hazard ratio for CVD per additional ICVHM was 0.82 (95% CI, 0.79-0.86) among participants with prediabetes and was 0.85 (95% CI, 0.80-0.89) among participants with diabetes. CONCLUSIONS AND RELEVANCE Participants with prediabetes or diabetes who had 5 or more ICVHMs exhibited lower or no significant excess CVD risks compared with the participants with normal glucose regulation.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 1 区 医学
小类 | 1 区 心脏和心血管系统
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 心脏和心血管系统
JCR分区:
出版当年[2017]版:
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
最新[2023]版:
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

影响因子: 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者单位: [1]Shanghai Jiao Tong Univ, Shanghai Natl Clin Res Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis,Natl Hlth Com, Key Lab Endocrine & Metab Dis,Ruijin Hosp,Sch Med, Shanghai, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:428 今日访问量:1 总访问量:411 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)